Previous 10 | Next 10 |
--News Direct-- Quest Diagnostics employees at the Cincinnati lab were thrilled about their local team, the Cincinnati Bengals, playing in this year’s Super Bowl against the Los Angeles Rams and came together to channel their excitement for a good cause. "You can certainly te...
A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...
Quest Diagnostics Incorporated (DGX) Q4 2021 Earnings Conference Call February 3, 2022, 08:30 AM ET Company Participants Shawn Bevec - VP of IR Steve Rusckowski - Chairman, CEO and President James E. Davis - EVP, General Diagnostics and CEO-Elect Mark Guinan - CFO Conference Call Participants...
--News Direct-- SECAUCUS, N.J., February 3, 2022 /3BL Media/ - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2022 for the eighth consecutive ...
The following slide deck was published by Quest Diagnostics Incorporated in conjunction with their 2022 Q4 earnings call. For further details see: Quest Diagnostics Incorporated 2022 Q4 - Results - Earnings Call Presentation
Quest Diagnostics (NYSE:DGX) is trading ~3% lower in the pre-market despite earnings beat after announcing a change in its leadership team. The company has named James E. Davis, Executive Vice President, General Diagnostics, as its new CEO effective Nov. 01, replacing Steve Rusckows...
Quest Diagnostics Announces Leadership Succession Plan -- Chairman and CEO Steve Rusckowski to remain CEO through October 2022 and continue as Executive Chairman -- James E. Davis, Executive Vice President, General Diagnostics, named CEO-elect, to succeed Mr. Rusckowski Nove...
Quest Diagnostics (NYSE:DGX) declares $0.66/share quarterly dividend, 6.5% increase from prior dividend of $0.62. Forward yield 1.94% Payable April 20; for shareholders of record April 6; ex-div April 5. See DGX Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see...
Quest Diagnostics press release (NYSE:DGX): Q4 Non-GAAP EPS of $3.33 beats by $0.14. Revenue of $2.74B (-8.7% Y/Y) beats by $80M. Full year 2022 reported diluted EPS expected to be between $7.63 and $8.33, and adjusted diluted EPS expected to be between $8.65 and $9.35 vs. $8.68B consensus. N...
QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2022; INCREASES QUARTERLY DIVIDEND 6.5% TO $0.66 PER SHARE - Full year revenues of $10.79 billion, up 14.3% from 2020 - Full year diluted earnings per share ("EPS")...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Quest Diagnostics Named a "Best Place to Work for Disability Inclusion" for Seventh Straight Year PR Newswire Quest achieves top score of 100 on 2024 Disability Equality Index® Best Places to Work for Disability Inclusion SECAUCUS, N.J. , Aug. 1, 20...
NORTHAMPTON, MA / ACCESSWIRE / July 30, 2024 / Bread of Life Academy, a program under nonprofit Bread of Life Inc. -a Quest for Health Equity (Q4HE) grantee-recently held a graduation ceremony to celebrate a graduating class of 40 students pursuing careers as phlebotomists and community health ...
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...